Mantle cell lymphoma epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 8: | Line 8: | ||
===Prevalence=== | ===Prevalence=== | ||
There are only about 15,000 patients presently in the U.S. (The prevalence seems to be somewhat higher in Europe.) | There are only about 15,000 patients presently in the U.S. (The prevalence seems to be somewhat higher in Europe.) | ||
===Age=== | |||
At diagnosis, the typical patient is in their 60s and usually presents to the oncologist with advanced disease. | |||
===Gender=== | ===Gender=== | ||
The ratio of males to females affected is about 4:1. | The ratio of males to females affected is about 4:1. | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Revision as of 13:07, 21 September 2012
|
Mantle cell lymphoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Mantle cell lymphoma epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Mantle cell lymphoma epidemiology and demographics |
|
Mantle cell lymphoma epidemiology and demographics in the news |
|
Risk calculators and risk factors for Mantle cell lymphoma epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Epidemiology and Demographics
Prevalence
There are only about 15,000 patients presently in the U.S. (The prevalence seems to be somewhat higher in Europe.)
Age
At diagnosis, the typical patient is in their 60s and usually presents to the oncologist with advanced disease.
Gender
The ratio of males to females affected is about 4:1.